共 50 条
Molecular dynamics and structural analysis of the binding of COP1 E3 ubiquitin ligase to β-catenin and TRIB pseudokinases
被引:4
|作者:
Zahid, Sana
[1
]
Basharat, Saba
[1
]
Fakhar, Muhammad
[1
]
Rashid, Sajid
[1
]
机构:
[1] Quaid I Azam Univ, Natl Ctr Bioinformat, Islamabad 42000, Pakistan
关键词:
COP1;
E3;
ligase;
molecular dynamics simulation;
TRIB1;
TRIB2;
TRIB3;
Tribbles homologs;
V-P motif;
WNT signaling;
beta-catenin phosphodegron motif;
NEGATIVE REGULATOR;
TUMOR-SUPPRESSOR;
C/EBP-ALPHA;
CANCER;
DOCKING;
HADDOCK;
SYSTEM;
D O I:
10.1002/prot.26292
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Tribbles pseudokinases, Tribbles homolog 1 (TRIB1), Tribbles homolog 2 (TRIB2), and Tribbles homolog 3 (TRIB3), bind to constitutive photomorphogenesis protein 1 (COP1) E3 ligase to mediate the regulation of beta-catenin expression. The interaction mechanism between COP1 E3 ligase and beta-catenin has not been addressed to date. Based on the functional presence of TRIBs in wingless-related integration site (WNT) signaling, we analyzed their interaction patterns with beta-catenin and COP1. Here, through in silico approaches, we ascribe the COP1 binding pattern against TRIBs and beta-catenin. TRIB1 (355-DQIVPEY-361), TRIB2 (326-DQLVPDV-332), and TRIB3 (333-AQVVPDG-339) peptides revealed a shallow binding pocket at the COP1 interface to accommodate the V-P sequence motif. Reinvigoration of the comparative binding pattern and subtle structural analysis via docking, molecular dynamics simulations, molecular mechanics Poisson-Boltzmann surface area, topological, and tunnel analysis revealed that both beta-catenin phosphodegron (DSGXXS) and TRIB (D/E/AQXVPD/E) motifs occupied a common COP1 binding site. Current study suggests a structural paradigm of TRIB homologs bearing a conserved motif that may compete with beta-catenin phosphodegron signature for binding to WD40 domain of COP1. Thorough understanding of the structural basis for TRIB-mediated regulation of WNT/beta-catenin signaling may help in devising more promising therapeutic strategy for liver and colorectal cancers.
引用
收藏
页码:993 / 1004
页数:12
相关论文